Login to Your Account

Pharma: Other News To Note

Tuesday, March 27, 2012
• Teva Pharmaceuticals Industries Ltd., of Jerusalem, said the FDA approved Qnasl, a dry nasal aerosol corticosteroid, for treating seasonal nasal and year-round nasal allergy symptoms in adults and adolescents 12 years and older. The product is expected to be available next month.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription